Together, T-96 decreased CXCR3 expression on CD8+ T cells from patients with vitiligo and blocked the chemotactic migration of CXCR3+CD8+ T cells under the CXCL9 and CXCL10 derived from inflamed keratinocytes. The gene discussed is CD8A; the disease is vitiligo.